Capitalbio Technology Co., Ltd. is a contract manufacturer and service company based in Beijing, China, operating as the industrialization platform of the CapitalBio Corporation and the Beijing National Engineering Research Center for Biochips. Established with 101 to 200 employees, the company integrates R&D, production, sales, and third-party independent medical laboratory services. Capitalbio Technology specializes in genetic detection and microarray technology, offering products such as Ngs Mutation Detection, Cnv-Seq Detection, Capitalbio® Microarray Scanner Luxscan™ 10K/D, Capitalbio® DNA Microarray Scanner Luxscan™ 10K, and Capitalbio® Microarray Hybridization Station. They also provide comprehensive genetic testing services, including those for hereditary cancers (e.g., BRCA1/2), blood cancer, and folic acid utilization ability. The company emphasizes independent innovation and achievement transformation, aligning with national health policies by integrating modern and traditional Chinese medicine to form a broad health industry section.
Genetic Testing of 18 Hereditary Cancer$10
Forensic Platform$10
Genetic Testing for Blood Cancer$10
Genetic Testing for Brca1/2 Targeted-Drug Guidance [ Germline + Somatic]$10
Genetic Testing for Hereditary Breast/Ovarian Cancer (BRCA1/2)$10
C&G Biotech Limited is a specialized manufacturer and service provider based in Hong Kong, established in 2008. The company operates as a contract manufacturer and raw material supplier for the In-Vitro Diagnostic (IVD) industry, maintaining a workforce of 11 to 50 employees. Their core product portfolio includes high-quality antigens, antibodies, and uncut sheets designed for use in rapid tests, ELISA, and chemiluminescence assays. C&G Biotech Limited is particularly noted for its production of Dengue Ns1 and NT-proBNP uncut sheets, which are engineered to help clients reduce manufacturing costs while maintaining high diagnostic standards. Beyond raw materials, the company leverages its proximity to clinical environments to provide IVD manufacturers with essential positive samples, including HIV, HCV, TP, HBV, and TB, for rigorous testing and validation. To support both startups and established firms, they offer comprehensive technical training aimed at assisting clients in establishing their own high-quality rapid test manufacturing lines. The company operates with a commitment to quality and reliability, backed by a factory and certifications including ISO 9001, ISO 13485, and GMP standards. Their mission focuses on delivering competitive pricing and consistent lot-to-lot quality for lateral flow reagents globally.